5-HT1-receptor-mediated vasoconstriction in bovine isolated pulmonary arteries: Influences of vascular endothelium and tone

Pulmonary Pharmacology

Volumn 7, Issue 1, 1994, Pages 65-72

  MacLean, M R ^a   Clayton, R A ^a   Hillis, S W ^a   McIntyre, P D ^a   Peacock, A J ^a   Templeton, A G B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

5 hydroxytryptamine(1D) receptor responses; Endothelial influences; Pulmonary arteries

Indexed keywords

ARGININE; DRUG DERIVATIVE; KETANSERIN; METITEPINE; N(G) NITROARGININE METHYL ESTER; NG NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; SEROTONIN; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; SUMATRIPTAN;

ANIMAL; ARTICLE; CATTLE; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; MUSCLE CONTRACTION; PHYSIOLOGY; PULMONARY ARTERY; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

AMINO ACID OXIDOREDUCTASES; ANIMAL; ARGININE; CATTLE; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; IN VITRO; KETANSERIN; METHIOTHEPIN; MUSCLE CONTRACTION; NG-NITROARGININE METHYL ESTER; NITRIC-OXIDE SYNTHASE; PULMONARY ARTERY; RECEPTORS, SEROTONIN; SENSITIVITY AND SPECIFICITY; SEROTONIN; SEROTONIN ANTAGONISTS; SUMATRIPTAN; SUPPORT, NON-U.S. GOV'T; VASOCONSTRICTION;

EID: 0028182642     PISSN: 09520600     EISSN: None     Source Type: Journal    
DOI: 10.1006/pulp.1994.1007     Document Type: Article

References (34)

1. lite receptor on dog saphenous vein. Br J Pharmacol 1988; 94: 1123-1132.
2. D binding sites. Eur J Pharmacol 1989; 163: 133-136.
3. ir binding sites in porcine brain can be differentiated by GR43175. Br J Pharmacol 1989; 97: 410P.
4. Humphrey P P A, Hartig P, Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sei 1993; 14: 233-236.
5. Doenicke A, Brand J, Perrin V L. Possible benefit of GR43175, a novel 5-HT, receptor agonist for the acute treatment of severe migraine. Lancet 1988; vol i: 1309-1311.
6. Bradley P B, Engel G, Feniuk W, Fozard J R, Humphrey PPA, Middlemass DN, Mylecharane EJ, Richardson B P, Saxena P R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 1986; 25: 563-576.
7. Connor H E, Feniuk W, Humphrey P P A. Characterisation of 5-HT receptors mediating contraction in dog and primate isolated basilar artery. Br J Pharmacol 1987; 92: 757P.
8. McIntyre P E, Bhargava B, Hogg K J, Gemmill J D, Hillis W S. The effect of i.v. sumatriptan, a selective 5-HT,-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol 1992; 34 (6): 541-546.
9. Templeton A G B, Clayton R A, McIntyre P D, Hillis W S, Peacock A J. Effect of sumatriptan and 5-HT in bovine pulmonary and mesenteric artery. Br J Pharmacol 1993; 108: 249P.
10. Sumner M J, Humphrey PPA. Sumatriptan (GR43I75) inhibits cyclic-AMP accumulation in dog isolated saphenous vein. Br J Pharmacol 1990; 99: 219-220.
11. Exton J H. Mechanisms involved in a-adrenergic phenomena. Am J Physiol 1985; 248: E633-647.
12. Templeton A G B, Macmillan J, McGrath J C, Storey N D, Wilson V G. Evidence for prazosin-resistant, rauwolscine-sensitive a-adrenoceptors mediating contractions in the isolated vascular bed of the rat tail. Br J Pharmacol 1989; 97: 563-571.
13. Mac Lean M R, McGrath J C. Effects of pre-contraction with endothelin-1 on a,-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated bed of the rat tail. Br J Pharmacol 1990; 101: 205-211.
14. MacLean M R, McCulloch K M, Macmillan J B, McGrath J C. Influences of the endothelium and hypoxia on neurogenic transmission in the isolated pulmonary artery of the rabbit. Br J Pharmacol 1993; 108: 150-154.
15. 3-adrenoceptor agonists in the rabbit isolated pulmonary artery. Br J Pharmacol 1993; 108: 155-161.
16. MacLean M R, McCulloch K M, Templeton A G B, Baird M. Comparison of rabbit neonate and adult pulmonary arterial responses to 5-hydroxytryptamine. Br J Pharmacol 1993; 110: 112P.
17. Daly C J, Gordon J F, McGrath J C. The use of fluorescent nuclear dyes for the study of blood vessel structure and function: novel applications of existing techniques. J Vase Res 1992; 29: 41-48.
18. Johnson D E, Georgieff M K. Pulmonary neuroendocrine cells. Their secretory products and their potential roles in health and chronic lung disease in infancy. Am Rev Respir Dis 1989; 140: 1807-1812.
19. Saxena P R, Villaion C M, Cardiovascular effects of serotonin agonists and antagonists. J Cardiovasc Pharmacol 1990; 15 (suppl. 7): S17-S34.
20. Frenken M, Kaumann A J. Interaction of ketanserin and its metabolite ketanserino with 5HT, receptors in pulmonary and coronary arteries of calf. Naunyn Schmiedebergs Arch Pharmacol 1984; 326: 334-339.
21. Parsons A A, Whalley E T, Feniuk W, Connor H E, Humphrey PPA. 5-HT,-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 1989; 96: 434-449.
22. Parsons A A, Whalley E T. Evidence for the presence of 5-HT,-like receptors in rabbit isolated basilar arteries. Eur J Pharmacol 1989; 174: 189-196.
23. Templeton A G B, Clayton R A, McIntyre P D, Hillis W S, Peacock A, MacLean M R. Sensitivity of human, bovine and rabbit pulmonary arteries to sumatriptan: comparison with 5-HT. Br J Pharmacol 1993; 110: 113P.
24. Reneman R S, Van Der Starre P J. Serotonin and acute cardiovascular disorders. Cardiovasc Drug Ther 1990; 4 (suppl. 1): 19-25.
25. Seibold J R, Molony R R, Turkevitc D, Ruddy M C, Kostis J B. Acute haemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis. J Rheumatol 1987; 14: 519-524.
26. Huct Y, Brun-Buisson C, Lemaire F, Teisseire B, Lhoste F, Rapin M, Cardiopulmonary effects of ketanserin infusion in human pulmonary embolism. Am Rev Respir Dis 1987; 135: 114—117.
27. D receptor subtype. J Pharmacol Exp Ther 1990; 252: 387-394.
28. Palmer R M J, Ferrige A G, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1988; 327: 524—526.
29. Rees D D, Palmer R M J, Hodson H F, Moncada S. A specific inhibitor of nitric oxide formation from L-argininc attenuates endothelium-dependent relaxation. Br J Pharmacol 1988; 96: 418-424.
30. MacLean M R, Smith G C, Templeton A G B. Adverse reactions to sumatriptan. Lancet 1993; 341: 1092- 1164.
31. Clayton R A, Templeton A G B, MacLean M R. cq-adrenoceptor- and S-hydroxytryptaminc mediated responses in bovine pulmonary arteries: the effect of vascular tone and forskolin. Br J Pharmacol 1993; 110: 111P.
32. Rabinovitch M, Bothwell T, Hayakawa B N, Williams W G, Trusler G A, Rowe R D, Olley P M, Cutz E. Pulmonary artery endothelial abnormalities in patients with congenital heart defects and pulmonary hypertension. Lab Invest 1986; 55: 63-653.
33. Dinh-Xuan A T. Endothelial dysfunction in chronic hypoxic pulmonary hypertension. J Vase Res 1992; 29: 103, 82P.
34. Adnot S, Kouyoumdjian M D, Fratacci M D, Defouilloy P, Andrivet S, Sediame S, Herigaut R. Responses to infusions of acetylcholine and inhaled nitric oxide in patient with chronic lung disease and pulmonary hypertension. J Vase Res 1992; 29: 76, 3P.